V
Vani Vannappagari
Researcher at Research Triangle Park
Publications - 44
Citations - 1060
Vani Vannappagari is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Medicine & Regimen. The author has an hindex of 10, co-authored 35 publications receiving 807 citations. Previous affiliations of Vani Vannappagari include University of North Carolina at Chapel Hill & ViiV Healthcare.
Papers
More filters
Journal ArticleDOI
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.
TL;DR: The magnitude and variation in global, regional, and country-level prevalence rates of G6PD deficiency are of public health import, particularly in planning programs to improve neonatal health and in the distribution of various medications, especially antimalarial drugs, as G6 PD deficiency is most prevalent in malaria-endemic areas.
Journal ArticleDOI
Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites
Robert C. Millikan,Jon Player,Allan René de Cotret,Patricia G. Moorman,Gary S. Pittman,Vani Vannappagari,Chiu Kit J. Tse,Temitope O. Keku +7 more
TL;DR: The MnSOD genotype may contribute to an increased risk of breast cancer in the presence of specific environmental exposures and provide further evidence for the importance of reactive oxygen species and of oxidative DNA damage in the etiology of Breast cancer.
Journal ArticleDOI
Psychiatric Symptoms in Patients Receiving Dolutegravir.
Anna Fettiplace,C. Stainsby,Alan Winston,Naomi Givens,Sarah Puccini,Vani Vannappagari,Ricky Hsu,Jennifer S Fusco,Romina Quercia,Michael Aboud,Lloyd Curtis +10 more
TL;DR: Analysis of 3 different data sources shows that, similar to other frequently prescribed anchor drugs to treat HIV infection, PSs are also reported in DTG-treated patients.
Journal ArticleDOI
Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy
TL;DR: The prevalence of severe thrombocytopenia was low, it occurred at levels associated with bleeding and was persistent among a small proportion of patients despite receipt of HAART.
Journal ArticleDOI
HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
Karam Mounzer,R Hsu,Jennifer S Fusco,Laurence Brunet,Cassidy Henegar,Vani Vannappagari,Chris M. Stainsby,Mark S. Shaefer,Leigh Ragone,Gregory Fusco +9 more
TL;DR: Frequency of HLA-B*57:01 screening increased steadily since its first inclusion in treatment guidelines in the United States, accompanied by a decreasing incidence of definite or probable hypersensitivity reactions over the same period.